Skip to main content

Table 2 Characteristics of non sentinel node and sentinel node

From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase

 

Number

Percent

NSLNs Examined

Median (range)

15 (11–52)

 

N° of positive NSLNs

610

40.8

Median (range)

2 (1–41)

N° of Copies (Highest copy number)

  ≤ 1500

305

20.4

  > 1500–12,000

329

22.0

  > 12,000–111,000

460

30.8

  > 111,000

401

26.8